Mineralys Therapeutics, Inc.
MLYS • NASDAQ • Stock Fundamentals
Mineralys Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jon Congleton, with a market cap of $2.1B.
Market Cap$2.1B
Employees28.0
CEOJon Congleton
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 6 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Mineralys Therapeutics, Inc. FAQ
Common questions about Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. (MLYS) has a market capitalization of $2.1B and trades on NASDAQ.
Mineralys Therapeutics, Inc. has approximately 28 employees.